Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome

• Status: Completed
• Trial end date: 2005-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This study assesses dopamine transporter density using single photon emission computed tomography (SPECT) brain imaging with an investigational radiopharmaceutical, [123I]ß-CIT, in research participants with Parkinson's disease.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Institute for Neurodegenerative Disorders
• Collaborators: Molecular NeuroImaging; National Institutes of Health (NIH)

Criteria

Inclusion Criteria:

• At least 21 years of age

• Normal screening laboratory studies

• At least two of the following: resting tremor, cogwheel rigidity, bradykinesia, and postural reflex impairment

Exclusion Criteria:

• Pregnancy

• Significant medical disease including abnormalities found on screening